In HCC, PEG-IFNα attracts CD8+ T cells by inducing CCL4 chemokine expression and upregulates PD-1 levels on these cells; subsequent PD-1 blockade restores T cell-mediated cytotoxicity, achieving a synergistic therapeutic effect against HCC (52). This evidence concerns the gene CD8A and hepatocellular carcinoma.